M&A Deal Summary

Kyphon Acquires St. Francis Medical Technologies

On December 4, 2006, Kyphon acquired medical products company St. Francis Medical Technologies from EW Healthcare Partners for 525M USD

Acquisition Highlights
  • This is Kyphon’s 1st transaction in the Medical Products sector.
  • This is Kyphon’s largest (disclosed) transaction.
  • This is Kyphon’s 1st transaction in the United States.
  • This is Kyphon’s 1st transaction in California.

M&A Deal Summary
Date 2006-12-04
Target St. Francis Medical Technologies
Sector Medical Products
Buyer(s) Kyphon
Sellers(s) EW Healthcare Partners
Deal Type Add-on Acquisition
Deal Value 525M USD

Target

St. Francis Medical Technologies

Alameda, California, United States
St. Francis Medical Technologies, Inc. manufactures the X-STOP Interspinous Process Decompression (IPD) System, the first FDA-approved interspinous process device for treating lumbar spinal stenosis.

Search 201,839 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kyphon

Sunnyvale, California, United States
Category Company
Founded 1994
Sector Medical Products
DESCRIPTION

Kyphon develops, manufactures and markets minimally invasive medical devices, which employ a proprietary balloon technology, to help surgeons repair spine fractures caused by osteoporosis, cancer and trauma. Kyphon was formed in 1994 and is based in Sunnyvale, California.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2006) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

EW Healthcare Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1985
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.

DEAL STATS #
Overall 9 of 53
Sector (Medical Products) 3 of 24
Type (Add-on Acquisition) 4 of 34
State (California) 3 of 17
Country (United States) 8 of 46
Year (2006) 4 of 4
Size (of disclosed) 4 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-07-18 Confluent Surgical

Waltham, Massachusetts, United States

Confluent Surgical, Inc.develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.

Sell $245M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-01-01 Oraya Therapeutics

Newark, California, United States

Oraya Therapeutics is a privately held, development-stage medical technology company, pioneering noninvasive radiation treatments for inflammatory and neovascular diseases of the eye.

Buy -
Mergr

Product

Company

Legal